1. Home
  2. TAK vs CARR Comparison

TAK vs CARR Comparison

Compare TAK & CARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAK
  • CARR
  • Stock Information
  • Founded
  • TAK 1781
  • CARR 2019
  • Country
  • TAK Japan
  • CARR United States
  • Employees
  • TAK N/A
  • CARR N/A
  • Industry
  • TAK Biotechnology: Pharmaceutical Preparations
  • CARR Industrial Machinery/Components
  • Sector
  • TAK Health Care
  • CARR Industrials
  • Exchange
  • TAK Nasdaq
  • CARR Nasdaq
  • Market Cap
  • TAK 47.3B
  • CARR 56.3B
  • IPO Year
  • TAK N/A
  • CARR N/A
  • Fundamental
  • Price
  • TAK $15.16
  • CARR $63.50
  • Analyst Decision
  • TAK
  • CARR Buy
  • Analyst Count
  • TAK 0
  • CARR 15
  • Target Price
  • TAK N/A
  • CARR $83.60
  • AVG Volume (30 Days)
  • TAK 3.1M
  • CARR 4.9M
  • Earning Date
  • TAK 10-30-2025
  • CARR 10-23-2025
  • Dividend Yield
  • TAK 3.58%
  • CARR 1.43%
  • EPS Growth
  • TAK N/A
  • CARR 17.18
  • EPS
  • TAK 0.59
  • CARR 4.49
  • Revenue
  • TAK $31,053,301,865.00
  • CARR $22,463,000,000.00
  • Revenue This Year
  • TAK $0.40
  • CARR $4.28
  • Revenue Next Year
  • TAK $0.83
  • CARR $6.13
  • P/E Ratio
  • TAK $25.64
  • CARR $14.04
  • Revenue Growth
  • TAK 1.52
  • CARR 9.02
  • 52 Week Low
  • TAK $12.80
  • CARR $54.22
  • 52 Week High
  • TAK $15.56
  • CARR $83.32
  • Technical
  • Relative Strength Index (RSI)
  • TAK 57.04
  • CARR 36.23
  • Support Level
  • TAK $14.90
  • CARR $65.25
  • Resistance Level
  • TAK $15.53
  • CARR $68.06
  • Average True Range (ATR)
  • TAK 0.13
  • CARR 1.60
  • MACD
  • TAK 0.01
  • CARR 0.08
  • Stochastic Oscillator
  • TAK 53.98
  • CARR 14.35

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

About CARR Carrier Global Corporation

Carrier Global provides HVAC and refrigeration products and services that serve the global residential, commercial, and transportation markets. The company's HVAC businesses account for approximately 85% of consolidated revenue, with residential and light commercial HVAC and commercial HVAC representing about 60% and 25% of total revenue, respectively. Carrier's refrigeration segment, which accounts for approximately 15% of consolidated revenue, consists of its transportation refrigeration and Sensitech supply chain monitoring products and services.

Share on Social Networks: